Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
103
-
Total 13F shares, excl. options
-
48,592,930
-
Shares change
-
+5,718,421
-
Total reported value, excl. options
-
$346,980,385
-
Value change
-
+$42,436,397
-
Put/Call ratio
-
74%
-
Number of buys
-
62
-
Number of sells
-
49
-
Price
-
$7.14
Institutional Holders of SUNESIS PHARMACEUTICALS INC - COM NEW (SNSS) as of Q3 2014
As of 30 Sep 2014 SUNESIS PHARMACEUTICALS INC - COM NEW (SNSS) had 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 48,592,930 shares of stock of the company.
Largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, LLC, Visium Asset Management, LP, Citadel Advisors LLC, EAGLE ASSET MANAGEMENT INC, VANGUARD GROUP INC, Lamond Capital Partners LLC, FRANKLIN RESOURCES INC, and ORBIMED ADVISORS LLC.
This table shows 157 institutional shareholders of the security as of 30 Sep 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.